TPCHRF - Round 6 - Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)

Status	Active
Effective start/end date	1/07/18 → 30/06/20